Skip to main content
Equibles

OPPENHEIMER ASSET MANAGEMENT INC.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1269119 NEW YORK, NY
Back to HALO Full portfolio

Position in HALO

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$2,277,499
+$366,456 QoQ
Shares Held
29,098
-1.6% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#225
of 667 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

OPPENHEIMER ASSET MANAGEMENT INC. holds $60,234,083 across 32 Biotechnology names. HALO ranks #6 (3.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GMAB
Genmab A/S
 447,426 $12,290,791
2 ONC
BeOne Medicines Ltd.
 35,781 $10,196,511
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 17,931 $8,906,863
4 ALNY
Alnylam Pharmaceuticals, Inc.
 19,608 $5,902,596
5 TECH
BIO-TECHNE Corp
 39,080 $2,760,999
6 HALO
Halozyme Therapeutics, Inc.
This page 		29,098 $2,277,499
7 JAZZ
Jazz Pharmaceuticals plc
 8,356 $2,013,545
8 INSM
INSMED Inc
 16,061 $1,712,423

All Filings in HALO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,277,499 29,098
2026-03-31 $1,911,043 29,569
2025-12-31 $1,968,726 29,253
2025-09-30 $2,281,900 31,114
2025-06-30 $2,106,549 40,495
2025-03-31 $2,668,086 41,813
2024-12-31 $1,999,796 41,828
2024-09-30 $2,854,615 49,871
2024-06-30 $1,356,384 25,905
2024-03-31 $919,245 22,597
2023-12-31 $928,360 25,118
2023-09-30 $1,075,138 28,145
2023-06-30 $1,013,242 28,091
2023-03-31 $1,071,572 28,059
2022-12-31 $2,616,944 45,992
2022-09-30 $1,701,326 43,028
2022-06-30 $1,709,972 38,863
2022-03-31 $1,541,241 38,647
2021-12-31 $1,532,000 38,100
2021-09-30 $1,740,533 42,786
2021-06-30 $1,497,710 32,982
2021-03-31 $1,375,768 33,000
2020-12-31 $977,673 22,891
2020-09-30 $591,457 22,506
2020-06-30 $586,065 21,860
2020-03-31 $61,327 3,409